Ask Questions About Clinical Trials: A Tool to Help Patients Discuss Trials
Official title: Ask Questions About Clinical Trials (ASQ - CT): An Implementation Trial of a Communication Intervention to Improve Patient-Provider Communication About Clinical Trials and Provider Invitations to Clinical Trials
Run by Barbara Ann Karmanos Cancer Institute · NCT07343297 · Data updated 2026-11-12
This study tests a patient-friendly brochure called the ASQ-CT to see if it helps adults with cancer, heart disease, or neurologic conditions talk with their providers about clinical trials.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 293 (estimated) |
| Sponsor | Barbara Ann Karmanos Cancer Institute Academic / other |
| Locations | 8 sites (Bay City, Michigan and 7 other locations) |
| Status | Recruiting |
| Started | December 30, 2026 |
| Main results expected | December 30, 2027 |
| Study ends | April 5, 2028 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT07343297 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who are receiving care at designated Karmanos/McLaren sites, potentially eligible for a clinical trial, and who can read and understand English to complete consent and surveys.
✕Probably not a fit
Patients who do not read English well or cannot complete study documents on their own may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study provides the ASQ-CT brochure to eligible adults at baseline and tracks responses at three timepoints: baseline, before the research visit, and after the visit. The goal is to understand how the brochure affects patient–provider communication regarding clinical trials. Participants are adults who speak English, are undergoing care at specified McLaren/Karmanos sites, and may be eligible for a clinical trial. The study uses a questionnaire to measure communication outcomes and perceptions related to clinical trials. Locations include three Michigan sites affiliated with Karmanos and McLaren, under the Barbara Ann Karmanos Cancer Institute as lead sponsor.
Why it matters
Potential benefit: Participants may experience improved understanding and communication about clinical trials, potentially helping them make informed treatment choices.
How similar studies have gone: Prior research on patient-facing trial information tools has shown promise in improving communication, but results can vary by setting and population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> or equal to 18 years * Appointment to see a provider at a Karmanos Cancer Institute-McLaren or a medical encounter at McLaren Center for Research and Innovation (MCRI) site for medical/systemic treatment * Potentially eligible for a clinical trial * Speak and read English well enough to be able to understand consent documents and complete surveys Exclusion Criteria: * Not able to complete study documents on their own physically or cognitively
Where it's running
-
Karmanos Cancer Institute at McLaren Bay Region
Bay City, Michigan, United States Recruiting -
Karmanos Cancer Institute at McLaren Clarkston
Clarkston, Michigan, United States Recruiting -
Karmanos Cancer Institute at McLaren Greater Lansing
Lansing, Michigan, United States Recruiting -
Karmanos Cancer Institute at McLaren Lapeer
Lapeer, Michigan, United States Recruiting -
Karmanos Cancer Institute at McLaren Macomb
Mount Clemens, Michigan, United States Recruiting -
Karmanos Cancer Institute at McLaren Central Michigan, Morey Cancer Center
Mount Pleasant, Michigan, United States Recruiting
Show 2 more locations
-
Karmanos Cancer Institute at McLaren Northern Michigan
Petoskey, Michigan, United States Recruiting -
Karmanos Cancer Institute at McLaren Port Huron
Port Huron, Michigan, United States Recruiting
Study contacts
- Principal investigator: Lauren M Hamel, PhD, MBA — Wayne State University
- Study coordinator: Lauren M Hamel, PhD, MBA
- Email: Lauren.Hamel@med.wayne.edu
- Phone: 1-800-527-6266
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Balance in Everyday Life for young MI patients with distress
This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.
-
Well-being program for caregivers of patients with advanced heart or lung disease
This study tests an 8-week, home-based wellness program delivered virtually to caregivers of people with advanced cardiac or pulmonary disease to see if it’s feasible and acceptable.
-
Digital diagnosis of newborn heart sounds
This project will test a digital, machine-learning tool that listens to newborn heart sounds to try to detect serious congenital heart problems in the first month of life.
-
Efferon LPS hemoadsorption during and after heart surgery
This trial tests whether using the Efferon® LPS filter during cardiopulmonary bypass and again within 24 hours afterward can lower the chance and severity of multiple organ dysfunction in adults having cardiac surgery who are at higher surgical risk.
-
Comparing preoperative cardiac clearance with the G60 Orthopedic Hip Frailty Index to predict outcomes after hip fracture surgery
This project will test whether preoperative cardiac clearance predicts short-term postoperative mortality better than the G60 Orthopedic Hip Frailty Index for people aged 60 and older who need surgical treatment for hip fractures.
-
Postoperative breathing problems after (adeno)tonsillectomy in children with sleep apnea
See how common breathing problems are after (adeno)tonsillectomy in children with obstructive sleep apnea and which factors raise the risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.